ITIH2 and colorectal cancer: For instance, elevated expression of ITIH2 in liver hepatocellular carcinoma (LIHC) patients was associated with longer overall survival (OS) (p = 0.019) [90], while increased expression of ITIH2 was associated with shorter OS in colorectal cancer patients that had liver metastases [91].